Clinical Trials Directory

Trials / Completed

CompletedNCT03751800

A Study Run at Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also be Used to Assess Changes of Severity of HMB in Women With HMB Who Are Treated During 12 Months With a Chronic Hormonal Treatment

An Observational, Prospective, Multicentre Study to Assess the Sensitivity to Change of the SAMANTA Questionnaire in Women With Heavy Menstrual Bleeding (HMB)

Status
Completed
Phase
Study type
Observational
Enrollment
422 (actual)
Sponsor
Bayer · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

A study run at multiple study sites in Spain to test whether the SAMANTA questionnaire that is used to diagnose heavy menstrual bleeding (HMB), can also be used to assess changes of severity of HMB in women with HMB who are treated during 12 months with a chronic hormonal treatment. Patients that are treated with chronic hormonal treatment as Levonorgestrel (trade name Mirena) or with a combination of estradiol valerate and dienogest (trade name Qlaira) or with Medroxyprogesterone acetate (trade name Progevera) and any new hormonal treatment marketed in Spain that has the indication for HMB in routine gynaecological practice are observed for 12 months in this study or for a shorter period in time in case of withdrawal. The study aims also to describe the overall satisfaction of women with their chronic hormonal treatment for HMB and how the women think their menstrual bleeding has changed. In addition the study aims to describe the changes of the score that is derived from the SAMANTA questionnaire in relation to Quality of Life. Quality of Life is measured with the SF36v2 questionnaire. The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health.

Conditions

Interventions

TypeNameDescription
DRUGChronic hormonal treatmentDrugs used in this study are described by the physicians during routine gynecological visits

Timeline

Start date
2018-12-12
Primary completion
2021-03-12
Completion
2021-05-18
First posted
2018-11-23
Last updated
2024-10-18

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03751800. Inclusion in this directory is not an endorsement.